SEARCH

SEARCH BY CITATION

FilenameFormatSizeDescription
path4201-sup-0001-Appendix S1.docxWord 2007 document18KAppendix S1. Supplementary Materials and Methods
path4201-sup-0002-Figure s1.tifTIFF image1943KAICAR treatment of LMP1-expressing NP69 cells. NP69-pLNSX and NP69-LMP1 cells were treated with increasing doses of AICAR for 2 hrs prior to harvesting and immunoblotting for the indicated proteins. Relative protein levels were calculated using drug free pLNSX vector control as a reference (set at 1). The ratios of pLKB1/LKB1 and pAMPKα/AMPKα were calculated and are shown in the form of bar charts.
path4201-sup-0003-Figure s2.tifTIFF image1834KAICAR treatment of LMP1-expressing C666-1 NPC cells. C666-1 cells were treated with various doses of AICAR and/or 5-FU for 2 hrs prior to harvesting and immunoblotting for the indicated proteins. Relative protein levels were calculated using drug free C666-1 cells as a reference (set at 1). The ratio of pAMPKα/AMPKα was calculated and shown as a bar chart.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.